Evidence map›Paper›PMID 37012130›Full record

ArticleEuropean urology2023

Erratum to "Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy" [Eur Urol 2022;81(5):446-55].

Qing Cheng, William Butler, Yinglu Zhou, Hong Zhang, Lu Tang, Kathryn Perkinson, Xufeng Chen, Xiaoyin Sara Jiang, Shannon J McCall, Brant A Inman and 1 more

Open access · greenAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in European urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Qing ChengDepartment of Surgery, Duke University School of Medicine, Durham, NC, USA; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA. Electronic address: Q.Cheng@duke.edu.
William ButlerDepartment of Pathology, Duke University School of Medicine, Durham, NC, USA.
Yinglu ZhouDepartment of Pathology, Duke University School of Medicine, Durham, NC, USA.
Hong ZhangDepartment of Pathology, Duke University School of Medicine, Durham, NC, USA.
Lu TangDepartment of Pathology, Duke University School of Medicine, Durham, NC, USA.
Kathryn PerkinsonDepartment of Pathology, Duke University School of Medicine, Durham, NC, USA.
Xufeng ChenDepartment of Pathology, Duke University School of Medicine, Durham, NC, USA.
Xiaoyin Sara JiangDuke Cancer Institute, Duke University School of Medicine, Durham, NC, USA; Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
Shannon J McCallDuke Cancer Institute, Duke University School of Medicine, Durham, NC, USA; Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
Brant A InmanDepartment of Surgery, Duke University School of Medicine, Durham, NC, USA; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA. Electronic address: brant.inman@duke.edu.
Jiaoti HuangDuke Cancer Institute, Duke University School of Medicine, Durham, NC, USA; Department of Pathology, Duke University School of Medicine, Durham, NC, USA. Electronic address: Jiaoti.Huang@duke.edu.
Duke University · US

Funding

Role of oncogenic phosphorylated MED1 in aggressive prostate cancerR01CA200853 · NCI · OHIO STATE UNIVERSITY · PI CLINTON, STEVEN K, HUANG, JIAOTI · 2017 to 2021
$1.9M
Histologic and Immunohistochemical Biomarkers for Heavily Treated Metastatic Prostate Cancer.R01CA205001 · NCI · DUKE UNIVERSITY · PI HUANG, JIAOTI · 2016 to 2020
$1.3M
NCI NIH HHS R01 CA200853NCI NIH HHS R01 CA205001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37012130
PMCPMC10353869
OpenAlexW4362453059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.